Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Kahlmeter

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Upsala Journal of Medical Sciences|May 20, 2014
Defining antibiotic resistance-towards international harmonizationGunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|June 20, 2015
The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?Gunnar Kahlmeter
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2022
How to: ECOFFs-the why, the how, and the don'ts of EUCAST epidemiological cutoff valuesGunnar Kahlmeter, John Turnidge
The Journal of Antimicrobial Chemotherapy|June 14, 2003
Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infectionsGunnar Kahlmeter, Paul Menday
Scandinavian Journal of Infectious Diseases|September 30, 2008
Staphylococci in primary skin and soft tissue infections in a Swedish countyMaria Sjolund, Gunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|March 3, 2007
Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive databaseMartin Sundqvist, Gunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|May 21, 2009
'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections failsMartin Sundqvist, Gunnar Kahlmeter
Clinical Microbiology Reviews|December 1, 2023
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utilityGunnar Kahlmeter, John Turnidge
Journal of Clinical Microbiology|August 6, 2005
Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureusR W Smyth, Gunnar Kahlmeter
International Journal of Antimicrobial Agents|November 8, 2011
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisitedGunnar Kahlmeter, Hanna Odén Poulsen
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Upsala Journal of Medical Sciences|May 20, 2014
Defining antibiotic resistance-towards international harmonizationGunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|June 20, 2015
The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?Gunnar Kahlmeter
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2022
How to: ECOFFs-the why, the how, and the don'ts of EUCAST epidemiological cutoff valuesGunnar Kahlmeter, John Turnidge
The Journal of Antimicrobial Chemotherapy|June 14, 2003
Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infectionsGunnar Kahlmeter, Paul Menday
Scandinavian Journal of Infectious Diseases|September 30, 2008
Staphylococci in primary skin and soft tissue infections in a Swedish countyMaria Sjolund, Gunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|March 3, 2007
Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive databaseMartin Sundqvist, Gunnar Kahlmeter
The Journal of Antimicrobial Chemotherapy|May 21, 2009
'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections failsMartin Sundqvist, Gunnar Kahlmeter
Clinical Microbiology Reviews|December 1, 2023
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utilityGunnar Kahlmeter, John Turnidge
Journal of Clinical Microbiology|August 6, 2005
Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureusR W Smyth, Gunnar Kahlmeter
International Journal of Antimicrobial Agents|November 8, 2011
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisitedGunnar Kahlmeter, Hanna Odén Poulsen
Pageof 10